Physician

Ryan M Klein, MD

According to 2025 Medicare claims, Ryan Klein, MD (NPI: 1184620866) practices internal medicine in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is NEWPORT SUPERIOR MEDICAL & INFUSION INC (NPI: 1184221137; TIN: 852428470) and primary practice location at 92663-3661.

Klein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 158,263 HCPCS/CPT codes, and received $2,224,619 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,548 prescription claims across 484 beneficiaries totaling $1,237,251 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 564 claims. Open Payments data shows 356 records totaling $883,831. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $139,190 to $2,224,619. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $532,721 to $1,237,251. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $18,218 to $27,004.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	248	2,135	$139,190
2016	284	3,227	$185,020
2017	313	3,423	$204,424
2018	332	2,946	$194,886
2019	365	3,048	$210,275
2020	449	2,903	$218,001
2021	364	6,247	$334,122
2022	409	32,216	$911,511
2023	468	105,005	$1,803,076
2024	510	158,263	$2,224,619

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	303	4,423	$532,721
2016	327	4,893	$510,624
2017	355	5,167	$512,373
2018	396	5,177	$563,448
2019	417	5,623	$670,971
2020	532	6,408	$1,004,625
2021	492	6,050	$949,633
2022	466	6,613	$952,243
2023	481	7,276	$1,225,161
2024	484	7,548	$1,237,251

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	82	$3,290
2016	11	124	$12,457
2017	11	210	$15,194
2018	70	314	$9,158
2019	100	492	$25,255
2020	141	636	$46,288
2021	145	552	$37,672
2022	117	441	$25,735
2023	168	527	$36,797
2024	149	564	$23,608

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	218	218	$151
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	224	226	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	330	1,131	$113
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	257	302	$13
96372	Injection of drug or substance under skin or into muscle	133	583	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	224	8,340	$174,022
Mounjaro	Tirzepatide	115	3,798	$135,547
Eliquis	Apixaban	190	7,161	$135,282
Breo Ellipta	Fluticasone/Vilanterol	124	5,040	$65,143
Januvia	Sitagliptin Phosphate	66	3,420	$61,165

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	74	$5,200
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	15	38	$3,063
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	25	53	$2,586
E0601	Continuous positive airway pressure (cpap) device	Y	13	85	$2,190
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	27	57	$2,166

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	163	$3,732	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	193	$880,099	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ryan M. Klein, MD?

Tedicare shows public-source Medicare data for Ryan M. Klein, MD (NPI 1184620866), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan M. Klein, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan M. Klein, MD?

Ryan M. Klein, MD is linked to NEWPORT SUPERIOR MEDICAL & INFUSION INC (billing NPI 1184221137) in the available physician profile data.

Does Ryan M. Klein, MD have Open Payments data?

Ryan M. Klein, MD has 356 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.